Literature DB >> 16788736

Ochronotic arthropathy: pathological evidence of acute destruction of the hip joint.

Ichiro Shimizu1, Tetsuo Hamada, Zain Khalpey, Keita Miyanishi, Toshihiko Hara.   

Abstract

Alcaptonuria is a hereditary disease, also known as black hip, where there is an accumulation of homogentisic acid pigmentation in joint cartilages. We describe a 74-year-old woman who showed acute destruction of her left hip joint. She received a total hip arthroplasty on her right side in July 2000, and was diagnosed with ochronosis. Her postoperative follow-up was at our institutions outpatient department. She first complained of increasing groin pain in July 2005, after which she had a left total hip arthroplasty in October 2005. Histopathologically, samples from this patient showed "fragmentation and cleft formation" in the cartilage of the femoral head. In addition, the samples revealed a remarkable degradation of proteoglycan, which is the secondary most abundant constituent of extra cellular matrix. These findings suggested that "cleft formation", where cracks develop toward the center, caused an acute destructive arthropathy with morphological fragility suggestive of ochronosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788736     DOI: 10.1007/s10067-006-0326-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  10 in total

1.  Detection and quantitation of proteoglycans extracted from cell culture medium and cultured cartilage slices.

Authors:  L J Hronowski; T P Anastassiades
Journal:  Anal Biochem       Date:  1988-11-01       Impact factor: 3.365

2.  Ochronotic arthropathy: rapid destructive hip osteoarthritis associated with metabolic disease.

Authors:  T Corrà; M Zaccala; M Galante
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

3.  [Rapidly progressing destructive diseases of the hip].

Authors:  M Lequesne
Journal:  Ann Radiol (Paris)       Date:  1993

4.  Ocular ochronosis. Clinicopathological, histochemical, and ultrastructural studies.

Authors:  A Kampik; J N Sani; W R Green
Journal:  Arch Ophthalmol       Date:  1980-08

5.  Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor.

Authors:  T Hamada; N Arima; M Shindo; K Sugama; Y Sasaguri
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

6.  A morphological study of bone and articular cartilage in ochronosis.

Authors:  M Di Franco; G Coari; E Bonucci
Journal:  Virchows Arch       Date:  2000-01       Impact factor: 4.064

7.  Cardiac ochronosis: valvular heart disease with dark green discoloration of the leaflets.

Authors:  Ersin Erek; Filip R A Casselman; Hugo Vanermen
Journal:  Tex Heart Inst J       Date:  2004

Review 8.  Ochronosis: a report of a case and a review of literature.

Authors:  Y T Konttinen; V Hoikka; M Landtman; H Saari; S Santavirta; K Metsärinne; J E Seegmiller
Journal:  Clin Exp Rheumatol       Date:  1989 Jul-Aug       Impact factor: 4.473

9.  Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue.

Authors:  S Björnsson
Journal:  Anal Biochem       Date:  1993-05-01       Impact factor: 3.365

10.  Natural history of alkaptonuria.

Authors:  Chanika Phornphutkul; Wendy J Introne; Monique B Perry; Isa Bernardini; Mark D Murphey; Diana L Fitzpatrick; Paul D Anderson; Marjan Huizing; Yair Anikster; Lynn H Gerber; William A Gahl
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

  10 in total
  4 in total

1.  Subchondral insufficiency fracture of the femoral head in a patient with alkaptonuria.

Authors:  Takahiro Hamada; Takuaki Yamamoto; Jun-ichi Shida; Akihiko Inokuchi; Takeshi Arizono
Journal:  Skeletal Radiol       Date:  2013-12-20       Impact factor: 2.199

Review 2.  Ochronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review.

Authors:  L Ventura-Ríos; C Hernández-Díaz; L Gutiérrez-Pérez; A Bernal-González; R Pichardo-Bahena; A L Cedeño-Garcidueñas; C Pineda
Journal:  Clin Rheumatol       Date:  2014-03-20       Impact factor: 2.980

3.  Alkaptonuria--case report.

Authors:  Fernanda Helena Craide; Juliana Salvini Barbosa Martins da Fonseca; Priscila Coelho Mariano; Natalia Monteiro Fernandez; Carlos Gustavo Carneiro de Castro; Yuri de Souza Lima Mene
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

4.  Treatment of osteoporotic fractures in alkaptonuria by teriparatide stimulates bone formation and decreases fracture rate - A report of two cases.

Authors:  L R Ranganath; M Khedr; A Mistry; S Vinjamuri; J A Gallagher
Journal:  Bone Rep       Date:  2021-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.